Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece (Q44266823)

1 December 2017

title

Clinical isolates of macrolide-resistant Streptococcus pyogenes in Central Greece (English)

1 reference

1 December 2017

main subject

Streptococcus pyogenes

object named as

Streptococcus pyogenes

1 reference

Petinaki E

1

1 reference

1 December 2017

Kontos F

2

1 reference

1 December 2017

Pratti A

3

1 reference

1 December 2017

Skulakis C

4

1 reference

1 December 2017

Maniatis AN

5

1 reference

1 December 2017

publication date

1 January 2003

1 reference

International Journal of Antimicrobial Agents

1 December 2017

published in

1 reference

1 December 2017

volume

21

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

67-70

1 reference

Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Clonal spread of group A streptococcus with the new type of erythromycin resistance. Finnish Study Group for Antimicrobial Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Erythromycin-resistant Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemiological and molecular study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes. The Argentinian Streptococcus Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Erythromycin resistance in Streptococcus pyogenes in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Erythromycin resistance amongst group A beta-haemolytic streptococci isolated in a paediatric hospital in Athens, Greece

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900253-4

7 January 2021

10.1016/S0924-8579(02)00253-4

Identifiers

DOI

1 reference

1 December 2017

1 reference